Biotech backer Ver­sant arms it­self with record $400M fund, tar­gets a new wave of up­starts

Ver­sant Ven­tures has once again racked up a record new biotech fund. Fund VI has land­ed, weigh­ing in at $400 mil­lion, well ahead of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.